Low osteocalcin/collagen type I bone gene expression ratio is associated with hip fragility fractures

Bone

Volumn 51, Issue 6, 2012, Pages 981-989

  Rodrigues, Ana M ^a,b   Caetano Lopes, Joana ^a   Vale, Ana C ^c   Vidal, Bruno ^a   Lopes, Ana ^a   Aleixo, Inês ^a   Polido Pereira, Joaquim ^a,b   Sepriano, Alexandre ^a,d   Perpétuo, Inês P ^a   Monteiro, Jacinto ^b   Vaz, Maria F ^c   Fonseca, João E ^a,b   Canhão, Helena ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^d Centro Hospitalar Lisboa Ocidental EPE   (Portugal)

Author keywords

Apolipoprotein E; Bone mechanical behavior; Fragility fractures; Osteocalcin; Osteoporosis

Indexed keywords

APOLIPOPROTEIN E4; COLLAGEN TYPE 1; ISOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; TRIACYLGLYCEROL; VITAMIN K GROUP;

AGE DISTRIBUTION; AGED; ARTICLE; BIOMECHANICS; BODY MASS; BONE MATRIX; BONE STRENGTH; BONE TURNOVER; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FEMUR EPIPHYSIS; FRAGILITY FRACTURE; GENE EXPRESSION; HIP ARTHROPLASTY; HIP FRACTURE; HIP OSTEOARTHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIGIDITY; SEX DIFFERENCE; TRABECULAR BONE;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; BONE AND BONES; CASE-CONTROL STUDIES; COLLAGEN TYPE I; FEMALE; GENOTYPE; HIP FRACTURES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OSTEOARTHRITIS; OSTEOCALCIN;

EID: 84867222853     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.08.129     Document Type: Article

References (59)

1. Cummings S.R., Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 359:1761-1767.
2. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
3. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 2010, 339:189-195.
4. Neve A., Corrado A., Cantatore F.P. Osteoblast physiology in normal and pathological conditions. Cell Tissue Res 2011, 343:289-302.
5. Tanaka S., Narusawa K., Onishi H., Miura M., Hijioka A., Kanazawa Y., et al. Lower osteocalcin and osteopontin contents of the femoral head in hip fracture patients than osteoarthritis patients. Osteoporos Int 2011, 22:587-597.
6. Hopwood B., Tsykin A., Findlay D.M., Fazzalari N.L. Gene expression profile of the bone microenvironment in human fragility fracture bone. Bone 2009, 44:87-101.
7. Caetano-Lopes J., Nery A.M., Henriques R., Canhao H., Duarte J., Amaral P.M., et al. Chronic arthritis directly induces quantitative and qualitative bone disturbances leading to compromised biomechanical properties. Clin Exp Rheumatol 2009, 27:475-482.
8. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382:448-452.
9. Balooch G., Balooch M., Nalla R.K., Schilling S., Filvaroff E.H., Marshall G.W., et al. TGF-beta regulates the mechanical properties and composition of bone matrix. Proc Natl Acad Sci U S A 2005, 102:18813-18818.
10. Lian J.B., Stein G.S., Stein J.L., van Wijnen A.J. Regulated expression of the bone-specific osteocalcin gene by vitamins and hormones. Vitam Horm 1999, 55:443-509.
11. Amizuka N., Li M., Kobayashi M., Hara K., Akahane S., Takeuchi K., et al. Vitamin K2, a gamma-carboxylating factor of gla-proteins, normalizes the bone crystal nucleation impaired by Mg-insufficiency. Histol Histopathol 2008, 23:1353-1366.
12. Ross P.D., Kress B.C., Parson R.E., Wasnich R.D., Armour K.A., Mizrahi I.A. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int 2000, 11:76-82.
13. Garnero P., Dargent-Molina P., Hans D., Schott A.M., Breart G., Meunier P.J., et al. Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study. Osteoporos Int 1998, 8:563-569.
14. Murshed M., Schinke T., McKee M.D., Karsenty G. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004, 165:625-630.
15. Furie B., Furie B.C. The molecular basis of blood coagulation. Cell 1988, 53:505-518.
16. Braam L.A., Knapen M.H., Geusens P., Brouns F., Hamulyak K., Gerichhausen M.J., et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60years of age. Calcif Tissue Int 2003, 73:21-26.
17. Bolton-Smith C., McMurdo M.E., Paterson C.R., Mole P.A., Harvey J.M., Fenton S.T., et al. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J Bone Miner Res 2007, 22:509-519.
18. Pan L.C., Price P.A. The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. Proc Natl Acad Sci U S A 1985, 82:6109-6113.
19. Watkins S.M., Zhu X., Zeisel S.H. Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice. J Nutr 2003, 133:3386-3391.
20. Shearer M.J. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 2000, 3:433-438.
21. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
22. Szulc P., Chapuy M.C., Meunier P.J., Delmas P.D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 1996, 18:487-488.
23. Vergnaud P., Garnero P., Meunier P.J., Breart G., Kamihagi K., Delmas P.D. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997, 82:719-724.
24. Gerdhem P., Ivaska K.K., Alatalo S.L., Halleen J.M., Hellman J., Isaksson A., et al. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 2004, 19:386-393.
25. Bauer D.C., Sklarin P.M., Stone K.L., Black D.M., Nevitt M.C., Ensrud K.E., et al. Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J Bone Miner Res 1999, 14:1404-1410.
26. Brown J.P., Delmas P.D., Malaval L., Edouard C., Chapuy M.C., Meunier P.J. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984, 1:1091-1093.
27. Hart J.P., Shearer M.J., Klenerman L., Catterall A., Reeve J., Sambrook P.N., et al. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J Clin Endocrinol Metab 1985, 60:1268-1269.
28. Hodges S.J., Pilkington M.J., Stamp T.C., Catterall A., Shearer M.J., Bitensky L., et al. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 1991, 12:387-389.
29. Hodges S.J., Akesson K., Vergnaud P., Obrant K., Delmas P.D. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res 1993, 8:1241-1245.
30. Lamon-Fava S., Sadowski J.A., Davidson K.W., O'Brien M.E., McNamara J.R., Schaefer E.J. Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am J Clin Nutr 1998, 67:1226-1231.
31. Newman P., Bonello F., Wierzbicki A.S., Lumb P., Savidge G.F., Shearer M.J. The uptake of lipoprotein-borne phylloquinone (vitamin K1) by osteoblasts and osteoblast-like cells: role of heparan sulfate proteoglycans and apolipoprotein E. J Bone Miner Res 2002, 17:426-433.
32. Saupe J., Shearer M.J., Kohlmeier M. Phylloquinone transport and its influence on gamma-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis. Am J Clin Nutr 1993, 58:204-208.
33. Weintraub M.S., Eisenberg S., Breslow J.L. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987, 80:1571-1577.
34. Parhami F., Garfinkel A., Demer L.L. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 2000, 20:2346-2348.
35. Cauley J.A., Zmuda J.M., Yaffe K., Kuller L.H., Ferrell R.E., Wisniewski S.R., et al. Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk-The Study of Osteoporotic Fractures. J Bone Miner Res 1999, 14:1175-1181.
36. Pluijm S.M., Dik M.G., Jonker C., Deeg D.J., van Kamp G.J., Lips P. Effects of gender and age on the association of apolipoprotein E epsilon4 with bone mineral density, bone turnover and the risk of fractures in older people. Osteoporos Int 2002, 13:701-709.
37. Peter I., Crosier M.D., Yoshida M., Booth S.L., Cupples L.A., Dawson-Hughes B., et al. Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis. Osteoporos Int 2011, 22:1199-1209.
38. Rodrigues A., Caetano-Lopes J., Nery A., Sousa E., Polido-Pereira J., Vale M., et al. Evaluation of bone mechanical strength and fracture risk assessment (Frax) in patients with hip joint replacement surgery. Acta Reumatol Port 2009, 34:504-510.
39. Weisgraber K.H., Rall S.C., Mahley R.W. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 1981, 256:9077-9083.
40. Smit M., de Knijff P., van der Kooij-Meijs E., Groenendijk C., van den Maagdenberg A.M., Gevers Leuven J.A., Stalenhoef A.F., et al. Genetic heterogeneity in familial dysbetalipoproteinemia. The E2(lys146-gln) variant results in a dominant mode of inheritance. J Lipid Res 1990, 31:45-53.
41. Egyhazi S., Bjohle J., Skoog L., Huang F., Borg A.L., Frostvik Stolt M., et al. Proteinase K added to the extraction procedure markedly increases RNA yield from primary breast tumors for use in microarray studies. Clin Chem 2004, 50:975-976.
42. Ireland D. Analysis of gene expression in bone by quantitative RT-PCR. Bone research protocols 2003, 433-440. Humana Press, New York. M.H. Helfrich, S.H. Ralston (Eds.).
43. Caetano-Lopes J., Lopes A., Rodrigues A., Fernandes D., Perpetuo I.P., Monjardino T., et al. Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. PLoS One 2011, 6:e16947.
44. Wong M.L., Medrano J.F. Real-time PCR for mRNA quantitation. Biotechniques 2005, 39:75-85.
45. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res 1996, 6:986-994.
46. Smith C.B., Smith D.A. Relations between age, mineral density and mechanical properties of human femoral compacta. Acta Orthop Scand 1976, 47:496-502.
47. Aleixo I., Vale A.C., Lúcio M., Amaral P.M., Rosa L.G., Caetano-Lopes J., et al. A method for the evaluation of femoral head trabecular bone compressive properties. Mater Sci Forum 2013, 730-732:3-8. (©(2013) Trans Tech Publications, Switzerland, http://dx.doi:10.4028/www.scientific.net/MSF.730-732.3).
48. Macdonald H.M., McGuigan F.E., Lanham-New S.A., Fraser W.D., Ralston S.H., Reid D.M. Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Am J Clin Nutr 2008, 87:1513-1520.
49. Jiang L.S., Zhang Z.M., Jiang S.D., Chen W.H., Dai L.Y. Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis. J Bone Miner Res 2008, 23:475-483.
50. Couchourel D., Aubry I., Delalandre A., Lavigne M., Martel-Pelletier J., Pelletier J.P., et al. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum 2009, 60:1438-1450.
51. Li B., Aspden R.M. Mechanical and material properties of the subchondral bone plate from the femoral head of patients with osteoarthritis or osteoporosis. Ann Rheum Dis 1997, 56:247-254.
52. Yu-Yahiro J.A., Michael R.H., Dubin N.H., Fox K.M., Sachs M., Hawkes W.G., et al. Serum and urine markers of bone metabolism during the year after hip fracture. J Am Geriatr Soc 2001, 49:877-883.
53. Li W.F., Hou S.X., Yu B., Li M.M., Ferec C., Chen J.M. Genetics of osteoporosis: accelerating pace in gene identification and validation. Hum Genet 2010, 127:249-285.
54. Kohlmeier M., Saupe J., Schaefer K., Asmus G. Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif Tissue Int 1998, 62:278-281.
55. Shiraki M., Shiraki Y., Aoki C., Hosoi T., Inoue S., Kaneki M., et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 1997, 12:1438-1445.
56. Tsezou A., Iliopoulos D., Malizos K.N., Simopoulou T. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes. J Orthop Res 2010, 28:1033-1039.
57. Lippiello L., Walsh T., Fienhold M. The association of lipid abnormalities with tissue pathology in human osteoarthritic articular cartilage. Metabolism 1991, 40:571-576.
58. Mahley R.W., Rall S.C. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000, 1:507-537.
59. Sun S.-S., Ma H.-L., Liu C.-L., Huang C.-H., Cheng C.-K., Wei W. Difference in femoral head and neck material properties between osteoarthritis and osteoporosis. Clin Biomech 2008, 23:S39-S47.